Anne H. Dantzig
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 44
- Drug Transport and Resistance Mechanisms 38
-
- Biochemical and Molecular Research 4
- Co-authors
- Robert L. Shepard (25 shared papers)James J. Starling (11 shared papers)Linda B. Tabas (12 shared papers)Susan E. Pratt (13 shared papers)Jin Cao (5 shared papers)Charles Pidgeon (2 shared papers)Steven Wrighton (7 shared papers)Mark A. Winter (7 shared papers)
- Journals
- Molecular Pharmacology (4 papers)Journal of Biological Chemistry (4 papers)Pharmaceutical Research (3 papers)Biochemical Pharmacology (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Anne H. Dantzig
62 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 108
- Oncology 2.1k
- Pediatrics, Perinatology and Child Health 646
- Pharmaceutical Science 219
- Pharmacology 299
- Biochemistry 215
Countries citing papers authored by Anne H. Dantzig
This map shows the geographic impact of Anne H. Dantzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne H. Dantzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne H. Dantzig more than expected).
Fields of papers citing papers by Anne H. Dantzig
This network shows the impact of papers produced by Anne H. Dantzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne H. Dantzig. The network helps show where Anne H. Dantzig may publish in the future.
Co-authors
The 25 scholars most cited alongside Anne H. Dantzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. | 1996 | 288 |
| 2 | 1995 | 225 | |
| 3 | 1990 | 200 | |
| 4 | 2005 | 187 | |
| 5 | 2002 | 155 | |
| 6 | 1994 | 153 | |
| 7 | 1999 | 149 | |
| 8 | 2002 | 138 | |
| 9 | 1999 | 124 | |
| 10 | 2002 | 112 | |
| 11 | 2003 | 100 | |
| 12 | 2009 | 95 | |
| 13 | 2013 | 91 | |
| 14 | 2002 | 87 | |
| 15 | 1997 | 70 | |
| 16 | 1994 | 68 | |
| 17 | 2003 | 63 | |
| 18 | 1992 | 57 | |
| 19 | 1994 | 56 | |
| 20 | 2002 | 55 |
About Anne H. Dantzig
Anne H. Dantzig is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Infectious Diseases and Biochemistry, having authored 62 papers that have together received 3.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (38 papers), Pharmacological Effects and Toxicity Studies (15 papers), HIV/AIDS drug development and treatment (8 papers), Amino Acid Enzymes and Metabolism (7 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Biochemical and Molecular Research (4 papers) and Adenosine and Purinergic Signaling (4 papers). The work is most often cited by research in Oncology (2.1k citations), Pediatrics, Perinatology and Child Health (646 citations), Pharmaceutical Science (219 citations), Pharmacology (299 citations) and Biochemistry (215 citations). Anne H. Dantzig has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Robert L. Shepard, James J. Starling, Linda B. Tabas, Susan E. Pratt, Jin Cao, Charles Pidgeon, Steven Wrighton, Mark A. Winter, William L. Perry and Cheng Yong Yang. Their work appears in journals such as Molecular Pharmacology, Journal of Biological Chemistry, Pharmaceutical Research, Biochemical Pharmacology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.